• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Clinical Response to Pulmonary Arterial Hypertension Treatment Does Not Depend on Pulmonary Arterial Wedge Pressure: A Meta-Analysis Using Individual Participant Data from Randomized Clinical Trials.肺动脉高压治疗的临床反应不取决于肺动脉楔压：一项使用随机临床试验个体参与者数据的荟萃分析
Am J Respir Crit Care Med. 2024 Sep 15;210(6):844-847. doi: 10.1164/rccm.202403-0612RL.
2
Use of an implantable wireless pulmonary pressure monitor during transition of therapy in pulmonary arterial hypertension.在肺动脉高压治疗转换期间使用植入式无线肺动脉压力监测仪。
J Heart Lung Transplant. 2019 Feb;38(2):227-230. doi: 10.1016/j.healun.2018.11.011. Epub 2018 Nov 24.
3
Efficacy and Safety of Treating Pulmonary Arterial Hypertension With Imatinib: A Meta-Analysis of Randomized Controlled Trials.伊马替尼治疗肺动脉高压的疗效与安全性：一项随机对照试验的荟萃分析
J Cardiovasc Pharmacol. 2025 Mar 1;85(3):177-185. doi: 10.1097/FJC.0000000000001665.
4
Repurposing Medications for Treatment of Pulmonary Arterial Hypertension: What's Old Is New Again.药物重新定位用于治疗肺动脉高压：旧药新用
J Am Heart Assoc. 2019 Jan 8;8(1):e011343. doi: 10.1161/JAHA.118.011343.
5
Could pulmonary arterial hypertension-specific agents be an option for Takayasu's arteritis related pulmonary hypertension?肺动脉高压特异性药物能否成为大动脉炎相关肺动脉高压的一种治疗选择？
Clin Exp Rheumatol. 2024 Apr;42(4):940-941. doi: 10.55563/clinexprheumatol/03vsp0. Epub 2023 Jul 5.
6
Current Trends and Future Perspectives in the Treatment of Pulmonary Arterial Hypertension.肺动脉高压治疗的现状与未来展望。
Curr Probl Cardiol. 2018 May;43(5):191-216. doi: 10.1016/j.cpcardiol.2017.10.002. Epub 2017 Oct 31.
7
Future Perspectives of Pulmonary Arterial Hypertension: A Review of Novel Pipeline Treatments and Indications.肺动脉高压的未来展望：新型在研治疗方法与适应症综述
Drugs R D. 2024 Mar;24(1):13-28. doi: 10.1007/s40268-024-00453-x. Epub 2024 Mar 22.
8
Pulmonary arterial hypertension treatment: an individual participant data network meta-analysis.肺动脉高压治疗：个体参与者数据网络荟萃分析。
Eur Heart J. 2024 Jun 1;45(21):1937-1952. doi: 10.1093/eurheartj/ehae049.
9
Sotatercept (Winrevair) for pulmonary arterial hypertension.用于治疗肺动脉高压的索他西普（Winrevair）。
Med Lett Drugs Ther. 2024 May 13;66(1702):73-75. doi: 10.58347/tml.2024.1702a.
10
Is There a Role for Calcium Channel Blockers in the Contemporary Treatment Paradigm for Pulmonary Arterial Hypertension?钙通道阻滞剂在当代肺动脉高压治疗模式中是否有作用？
Circulation. 2024 May 14;149(20):1565-1567. doi: 10.1161/CIRCULATIONAHA.124.069124. Epub 2024 May 13.

引用本文的文献

1
Decoding the enigmatic estrogen paradox in pulmonary hypertension: delving into estrogen metabolites and metabolic enzymes.解读肺动脉高压中神秘的雌激素悖论：深入探究雌激素代谢产物和代谢酶
Cell Mol Biol Lett. 2024 Dec 18;29(1):155. doi: 10.1186/s11658-024-00671-w.
2
Highlights for the Heart Failure Cardiologist from the Seventh World Symposium on Pulmonary Hypertension: Are We Out of the Woods Yet?第七届世界肺动脉高压研讨会给心力衰竭心脏病专家的启示：我们是否已脱离困境？
J Card Fail. 2025 Jan;31(1):127-131. doi: 10.1016/j.cardfail.2024.09.009. Epub 2024 Sep 27.
3
Definition, classification and diagnosis of pulmonary hypertension.肺动脉高压的定义、分类和诊断。
Eur Respir J. 2024 Oct 31;64(4). doi: 10.1183/13993003.01324-2024. Print 2024 Oct.

本文引用的文献

1
Pulmonary arterial wedge pressure in healthy subjects: a meta-analysis.健康受试者肺动脉楔压的荟萃分析。
Eur Respir J. 2024 Aug 15;64(2). doi: 10.1183/13993003.00967-2024. Print 2024 Aug.
2
"This Patient Needs a Doctor, Not a Guideline!" The Zone of Uncertainty in Pulmonary Arterial Wedge Pressure Measurement.“这位患者需要的是医生，而非指南！”肺动脉楔压测量中的不确定性区域
Am J Respir Crit Care Med. 2024 Sep 15;210(6):712-714. doi: 10.1164/rccm.202402-0359VP.
3
Pulmonary arterial hypertension treatment: an individual participant data network meta-analysis.肺动脉高压治疗：个体参与者数据网络荟萃分析。
Eur Heart J. 2024 Jun 1;45(21):1937-1952. doi: 10.1093/eurheartj/ehae049.
4
Implications of Mean Pulmonary Arterial Wedge Pressure Trajectories in Pulmonary Arterial Hypertension.肺动脉楔压轨迹变化对肺动脉高压的影响。
Am J Respir Crit Care Med. 2024 Feb 1;209(3):316-324. doi: 10.1164/rccm.202306-1072OC.
5
Minimal Clinically Important Difference in the 6-minute-walk Distance for Patients with Pulmonary Arterial Hypertension.肺动脉高压患者 6 分钟步行距离的最小临床重要差异。
Am J Respir Crit Care Med. 2023 Apr 15;207(8):1070-1079. doi: 10.1164/rccm.202208-1547OC.
6
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Respir J. 2023 Jan 6;61(1). doi: 10.1183/13993003.00879-2022. Print 2023 Jan.
7
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.2022年欧洲心脏病学会/欧洲呼吸学会肺动脉高压诊断和治疗指南。
Eur Heart J. 2022 Oct 11;43(38):3618-3731. doi: 10.1093/eurheartj/ehac237.
8
BMI and Treatment Response in Patients With Pulmonary Arterial Hypertension: A Meta-analysis.肺动脉高压患者的体重指数与治疗反应：一项荟萃分析。
Chest. 2022 Aug;162(2):436-447. doi: 10.1016/j.chest.2022.02.041. Epub 2022 Mar 3.
9
Secular and Regional Trends among Pulmonary Arterial Hypertension Clinical Trial Participants.肺动脉高压临床试验参与者的世俗和地域趋势。
Ann Am Thorac Soc. 2022 Jun;19(6):952-961. doi: 10.1513/AnnalsATS.202110-1139OC.
10
A Semi-Automated Term Harmonization Pipeline Applied to Pulmonary Arterial Hypertension Clinical Trials.一种应用于肺动脉高压临床试验的半自动术语协调管道。
Methods Inf Med. 2022 May;61(1-02):3-10. doi: 10.1055/s-0041-1739361. Epub 2021 Nov 24.

Clinical Response to Pulmonary Arterial Hypertension Treatment Does Not Depend on Pulmonary Arterial Wedge Pressure: A Meta-Analysis Using Individual Participant Data from Randomized Clinical Trials.

作者信息

Kovacs Gabor, Moutchia Jude, Zeder Katarina, Maron Bradley A, Al-Naamani Nadine, Ventetuolo Corey, Olschewski Horst, Kawut Steven M

机构信息

Division of Pulmonology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

Ludwig Boltzmann Institute for Lung Vascular Research, Graz, Austria.

出版信息

Am J Respir Crit Care Med. 2024 Sep 15;210(6):844-847. doi: 10.1164/rccm.202403-0612RL.

DOI:10.1164/rccm.202403-0612RL
PMID:38980192
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12056748/
Abstract
摘要